0001686266-18-000007.txt : 20180622 0001686266-18-000007.hdr.sgml : 20180622 20180622162807 ACCESSION NUMBER: 0001686266-18-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180622 DATE AS OF CHANGE: 20180622 EFFECTIVENESS DATE: 20180622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ReShape Lifesciences Inc. CENTRAL INDEX KEY: 0001371217 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 481293684 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-315244 FILM NUMBER: 18914837 BUSINESS ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 BUSINESS PHONE: 9494296680 MAIL ADDRESS: STREET 1: 1001 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 FORMER COMPANY: FORMER CONFORMED NAME: EnteroMedics Inc DATE OF NAME CHANGE: 20060802 D 1 primary_doc.xml X0708 D LIVE 0001371217 ReShape Lifesciences Inc. 1001 CALLE AMANECER SAN CLEMENTE CA CALIFORNIA 92673 9494296680 DELAWARE EnteroMedics Inc Corporation true Dan Gladney 1001 CALLE AMANECER San Clemente CA CALIFORNIA 92673 Executive Officer Director Scott Youngstrom 1001 CALLE AMANECER San Clemente CA CALIFORNIA 92673 Executive Officer Gary Blackford 1001 CALLE AMANECER San Clemente CA CALIFORNIA 92673 Director Jon Tremmel 1001 CALLE AMANECER San Clemente CA CALIFORNIA 92673 Director Lori McDougal 1001 CALLE AMANECER San Clemente CA CALIFORNIA 92673 Director Other Health Care Decline to Disclose 06b false 2018-06-07 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 CA CALIFORNIA FL FLORIDA NJ NEW JERSEY NY NEW YORK false 1235413 1235413 0 The warrants and underlying shares of common stock include warrants (i) to purchase 280,929 shares of common stock issued to certain institutional investors and (ii) to purchase 26,220 shares of common stock to H.C. Wainwright ("HCW Warrants"). false 4 2809 0 H.C. Wainwright received the above sales commission in connection with the private placement of warrants. The HCW Warrants were issued to H.C. Wainwright in connection with a registered direct offering by the Company, which is not reported on this Form D. 0 false ReShape Lifesciences Inc. /s/ Scott Youngstrom Scott Youngstrom CFO and Chief Compliance Officer 2018-06-22